Game On Land

Gamida Cell Stock Price

Gamida Cell Stock Price. (nasdaq:gmda) price on friday, december 31, rose 0.40% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $2.54. Gamida cell ltd's share price could reach $13.67 by nov 16, 2022.

GMDA Gamida Cell Stock Price
GMDA Gamida Cell Stock Price from stocklight.com

About the gamida cell ltd. — stock price and discussion | stocktwits. As of 2022 january 13, thursday current price of gmda stock is 2.330$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).

The Average Gamida Cell Ltd Stock Price Prediction Forecasts A Potential Upside Of 502.07% From The Current Gmda Share Price Of $2.27.

(nasdaq:gmda) price on friday, december 31, rose 0.40% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $2.54. With gamida cell ltd stock trading at $2.72 per share, the total value of gamida cell ltd stock (market capitalization) is $201.62m. Stock analysis for gamida cell ltd (gmda:nasdaq gm) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

See also  Punching Machine Game Price

Gamida Cell Ltd (Gmda) 3.24 +0.28 ( +9.46% ) Usd | Nasdaq | Jan 21, 16:00

On average, they anticipate gamida cell's share price to reach $14.60 in the next twelve months. Gamida cell ltd's share price could reach $13.67 by nov 16, 2022. The company's shares closed last wednesday at.

Their Forecasts Range From $11.00 To $22.00.

This suggests a possible upside of 393.2% from the stock's current price. Get the latest gamida cell ltd. (gmda) stock rallied over 9.46% intraday to trade at $3.24 a share on nasdaq.

A Look At The Stock’s Price Movement, The Close In The Last Trading Session Was $2.53, Moving Within A Range At $2.52 And

On average, wall street analysts predict that. About the gamida cell ltd. Gmda), an advanced cell therapy company committed to finding cures for blood cancers and serious blood diseases, today announced the pricing of an underwritten public offering of 13,333,334 ordinary shares at a public offering price of $4.50 per share for aggregate gross proceeds of approximately $60 million,.

Summary Of All Time Highs, Changes And Price Drops For Gamida Cell;

Jmp securities thinks gamida cell’s stock is going to recover. According to the issued ratings of 5 analysts in the last year, the consensus rating for gamida cell stock is buy based on the current 5 buy ratings for gmda. — stock price and discussion | stocktwits.

close